Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUDITOR: Rimonabant for Atherosclerosis Progression
NCT00228176Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Aug 2005
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of rimonabant in atherosclerosis, sponsored by Sanofi. Started Aug 2005; status: terminated.
02
Drugs
rimonabant
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00228176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228176.